Evidence map›Paper›PMID 19931603›Full record

ArticleToxicology letters2010

The role of damage associated molecular pattern molecules in acetaminophen-induced liver injury in mice.

Brittany V Martin-Murphy, Michael P Holt, Cynthia Ju

Open access · greenAbstract read
In one paragraph

Article in Toxicology letters, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 105 papers.

0numbers the graph read from it
0cells of the map it votes in
105citing papers in PubMed
13.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

105 citing papers in PubMed, 222 citations in OpenAlex.

  1. Trial
  2. HBV/HCV coinfection and anti-tuberculosis drug-induced liver injury: from risk assessment and exploration of mechanisms to preventive considerations.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Review
  3. Mesenchymal Stromal Cell-Based Cell-Drug Conjugates for the Treatment of Acute Liver Failure.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Hepatoprotective Effect ofFrontiers in pharmacology · 2022
    Article
  19. Article
  20. Article

45 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Brittany V Martin-MurphyDepartment of Pharmaceutical Sciences, University of Colorado Denver, Aurora, CO 80045, USA.
Michael P Holt
Cynthia Ju
University of Colorado Denver · US

Funding

The immunosuppressive role of hepatic Kupffer cellsR01ES012914 · NIEHS · UNIVERSITY OF COLORADO DENVER · PI JU, CYNTHIA · 2005 to 2009
$1.3M
Investigation of the role of DAMP molecules in the pathogenesis of Liver InjuryF31DK082269 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI MURPHY, BRITTANY V · 2008 to 2012
$127k
NIDDK NIH HHS F31 DK082269NIDDK NIH HHS F31DK082269NIEHS NIH HHS R01 ES012914NIEHS NIH HHS R01ES012914
6 · The paper itself

Abstract

The idiosyncratic nature, severity and poor diagnosis of drug-induced liver injury (DILI) make these reactions a major safety issue during drug development, as well as the most common cause for the withdrawal of drugs from the pharmaceutical market. Elucidation of the underlying mechanism(s) is necessary for identifying predisposing factors and developing strategies in the treatment and prevention of DILI. Acetaminophen (APAP) is a widely used over the counter therapeutic that is known to be effective and safe at therapeutic doses. However, in overdose situations fatal and non-fatal hepatic necrosis can result. Evidence suggests that the chemically reactive metabolite of the drug initiates hepatocyte damage and that inflammatory innate immune responses also occur within the liver, leading to the exacerbation and progression of tissue injury. Here we investigate whether following APAP-induced liver injury (AILI) damaged hepatocytes release "danger" signals or damage associated molecular pattern (DAMP) molecules, which induce pro-inflammatory activation of hepatic macrophages, further contributing to the progression of liver injury. Our study demonstrated a clear activation of Kupffer cells following early exposure to APAP (1h). Activation of a murine macrophage cell line, RAW cells, was also observed following treatment with liver perfusate from APAP-treated mice, or with culture supernatant of APAP-challenged hepatocytes. Moreover, in these media, the DAMP molecules, heat-shock protein-70 (HSP-70) and high mobility group box-1 (HMGB1) were detected. Overall, these findings reveal that DAMP molecules released from damaged and necrotic hepatocytes may serve as a crucial link between the initial hepatocyte damage and the activation of innate immune cells following APAP-exposure, and that DAMPs may represent a potential therapeutic target for AILI.

Indexed as

AcetaminophenAnalgesics, Non-NarcoticAnimalsCell LineChemical and Drug Induced Liver InjuryFemaleHMGB1 ProteinHSP70 Heat-Shock ProteinsImmunoblottingInterleukin-1betaInterleukin-6LiverMacrophage ActivationMiceMice, Inbred C57BLReverse Transcriptase Polymerase Chain ReactionAcetaminophenAnalgesics, Non-NarcoticHMGB1 ProteinHSP70 Heat-Shock ProteinsInterleukin-1betaInterleukin-6Tumor Necrosis Factor-alpha

Identifiers

PMID19931603
PMCPMC2822049
OpenAlexW2073010239

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.